Conference abstract · 2 Nov 2015
Conference abstractPublished 2 Nov 2015
Docking-Based Comparative Intermolecular Contacts Analysis As New Structure-Based Drug Design Approach
The Jordan University Jordan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The significant role played by docking algorithms in drug discovery combined with their serious pitfalls prompted us to envisage a novel concept for validating docking solutions, namely, docking-based comparative intermolecular contacts analysis (dbCICA). This novel approach is based on the number and quality of contacts between docked ligands and amino acid residues within the binding pocket. It assesses a particular docking configuration on the basis of its ability to align a set of ligands within a corresponding binding pocket in such a way that potent ligands come into contact with binding site spots distinct from those approached by low-affinity ligands and vice versa. In other words, dbCICA evaluates the consistency of docking by assessing the correlation between ligands' affinities and their contacts with binding site spots. Optimal dbCICA models can be translated into valid pharmacophore models that can be used as 3-D search queries to mine structural databases for new bioactive compounds. dbCICA was implemented to search for new inhibitors of candida N-myristoyl transferase as potential antifungal agents and glycogen phosphorylase (GP) inhibitors as potential antidiabetic agents. The process culminated in five selective micromolar antifungal leads and nine GP inhibitory leads.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 3 May 2019
In silico design of new MPS1 inhibitors via a validated structure-based virtual screening approach
Conference abstract · 11 Aug 2015
Current progress in structure-based rational drug design marks a new mindset in drug discovery
Perspective · 29 Oct 2024
Structure-Based Drug Design: A Strategic Approach to Targeted Therapeutics
Conference abstract · 14 Jun 2018
Molecular docking study and structure-based design of novel camptothecin analogues used as topoisomerase I inhibitor
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Mutasem O. Taha”
